| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma. | Ann Oncol | 2014 | 1.63 |
| 2 | Basal cell carcinomas in a tertiary referral centre: a systematic analysis. | Br J Dermatol | 2014 | 1.46 |
| 3 | First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). | Ann Oncol | 2011 | 1.16 |
| 4 | From chemotherapy to targeted treatment. | Ann Oncol | 2012 | 0.75 |